входит в структуру портала
News

Gates Foundation Invests $40 Million in UK Immunotherapy Company

September 20, 2017

The Bill and Melinda Gates Foundation is to invest up to $40 million in privately held British biotech company Immunocore to support its development of immunotherapies for infectious diseases.

Oxford-based Immunocore has so far concentrated on developing its T-cell receptor medicines to fight cancer, where it has collaborations with Roche, GlaxoSmithKline , AstraZeneca and Eli Lilly.

The tie-up with the Gates Foundation will extend the work into finding and developing new treatments for tuberculosis, HIV and other infectious diseases.

Source

Login
Remember me
Lost your Password?
Password Reset
Login